Drug Discovery, Development and Delivery unit (CSA327)

Introduction

This unit covers the study of novel therapeutics, emerging biological drugs as well as new drug targets and therapies. You will also be introduced to new drug delivery systems and medical devices promoting the integration and application of prior pharmacology knowledge into clinical practice. You will undertake patient counselling on emerging medicines and devices to integrate theory and knowledge. 

Summary

Unit name	Drug Discovery, Development and Delivery
Unit code	CSA327
Credit points	12.5
College/School	Health School of Pharmacy and Pharmacology
Discipline	Pharmacy
Coordinator	Doctor Vanni Caruso
Available as an elective?	No
Delivered By	University of Tasmania
Level	Advanced

Availability

Specific information on 2027 unit availability will be available in August

Learning Outcomes

• Apply drug and delivery device knowledge to improve patient outcomes.
• Explain the regulatory frameworks and processes that govern the entry of drugs and/or delivery devices in the Australian market.
• Effectively communicate drug and delivery device information in a patient-centred way.

Fee Information

2027 fee information will be available in August.

Requisites

Prerequisites

CSA357

Teaching

Teaching Pattern	Independent Learning  – 3hrs per week Workshop 3hrs weekly (7 weeks)
Assessment	In-class Assessment (20%)|End of Semester Presentation (40%)|In-class Prescription Counselling (40%)
Timetable	View the lecture timetable | View the full unit timetable

Textbooks

Required	No required reading materials

The University reserves the right to amend or remove courses and unit availabilities, as appropriate.